Skip to content

Clinical trials

Phase 2 Asthma trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Asthma Phase: Phase 2 Country / region: South Korea Clear all

39 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20073
20093
20104
20112
20125
20133
20141
20152
20161
20212
20222
20234
20244
20253

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed29
Terminated6
Recruiting2
Active, not recruiting1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca6
Novartis Pharmaceuticals6
Sanofi6
GlaxoSmithKline4
Amgen3
Boehringer Ingelheim3
Upstream Bio Inc.2
AbbVie1
Chiesi Farmaceutici S.p.A.1
Hoffmann-La Roche1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Asthma39
Lung Diseases4
Respiratory Tract Diseases4
Bronchial Diseases3
Respiratory Sounds2
Airway Obstruction1
Dyspnea1
Hypersensitivity1
Lung Diseases, Obstructive1
Respiratory Hypersensitivity1

Trials

Showing 1 to 25 of 39. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.